Data from in vivo mouse models indicate that delivery of the DMAb sequence for the influenza A-targeted monoclonal antibody protected
against lethal doses of two very different, clinically relevant influenza A viruses.
Not exact matches
«It was not known whether any of these vaccines could provide protection
against the new outbreak West African Makona strain of Ebola Zaire currently circulating in Guinea,» said John Eldridge, Chief Scientific Officer - Vaccines at Profectus Biosciences, Inc. «Our findings show that our candidate vaccines provided complete, single
dose protection from a
lethal amount of the Makona strain of Ebola virus.»
Not only were the mice protected from
lethal doses of flu virus, but the protection was also in large part due to the absence of familiar antibodies
against the head, the researchers found.
What's more, when Galli's team injected the IgE antibodies into mice that had never been exposed to the venom, those animals were also protected
against a potentially
lethal dose.
When the researchers exposed chickens to
lethal doses of the avian influenza virus and the Newcastle virus, birds inoculated with the recombinant vaccine produced antibodies
against both viruses, offering protection
against both diseases.
In fact, in one study, a
dose of mercury sufficient to kill 1 percent of lab rats (
lethal dose «LD01»), when combined with a
dose of lead sufficient to kill 1 percent, killed 100 percent of the rats.13 A similar test involving mercury and aluminum in cultured neurons killed 60 percent of the cells when the two low -
dose toxicants (LD01) were combined.14 Even antibiotics have been shown to enhance the uptake, retention and toxicity of mercury.14 Additionally, testosterone appears to aggravate mercury toxicity during development, while estrogen protects
against it.15 This may explain why more boys than girls are diagnosed with autism spectrum disorders and attention deficit disorders.